•
Suzhou Jiecheng Medical Technology Co., Ltd has announced that it has obtained Breakthrough Devices Designation (BDD) from the US Food and Drug Administration (FDA) for its proprietary transvascular interventional biological aortic valve. The device is designed for the treatment of severe aortic valve regurgitation (insufficiency) and mixed aortic valve disease…